Correlation Between Arcus Biosciences and Centessa Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Arcus Biosciences and Centessa Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arcus Biosciences and Centessa Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arcus Biosciences and Centessa Pharmaceuticals PLC, you can compare the effects of market volatilities on Arcus Biosciences and Centessa Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arcus Biosciences with a short position of Centessa Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arcus Biosciences and Centessa Pharmaceuticals.
Diversification Opportunities for Arcus Biosciences and Centessa Pharmaceuticals
-0.18 | Correlation Coefficient |
Good diversification
The 3 months correlation between Arcus and Centessa is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Arcus Biosciences and Centessa Pharmaceuticals PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Centessa Pharmaceuticals and Arcus Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arcus Biosciences are associated (or correlated) with Centessa Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Centessa Pharmaceuticals has no effect on the direction of Arcus Biosciences i.e., Arcus Biosciences and Centessa Pharmaceuticals go up and down completely randomly.
Pair Corralation between Arcus Biosciences and Centessa Pharmaceuticals
Given the investment horizon of 90 days Arcus Biosciences is expected to under-perform the Centessa Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Arcus Biosciences is 1.36 times less risky than Centessa Pharmaceuticals. The stock trades about -0.34 of its potential returns per unit of risk. The Centessa Pharmaceuticals PLC is currently generating about -0.09 of returns per unit of risk over similar time horizon. If you would invest 1,687 in Centessa Pharmaceuticals PLC on October 13, 2024 and sell it today you would lose (123.00) from holding Centessa Pharmaceuticals PLC or give up 7.29% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Arcus Biosciences vs. Centessa Pharmaceuticals PLC
Performance |
| Timeline |
| Arcus Biosciences |
| Centessa Pharmaceuticals |
Arcus Biosciences and Centessa Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Arcus Biosciences and Centessa Pharmaceuticals
The main advantage of trading using opposite Arcus Biosciences and Centessa Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arcus Biosciences position performs unexpectedly, Centessa Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Centessa Pharmaceuticals will offset losses from the drop in Centessa Pharmaceuticals' long position.| Arcus Biosciences vs. Cullinan Oncology LLC | Arcus Biosciences vs. Annexon | Arcus Biosciences vs. Structure Therapeutics American | Arcus Biosciences vs. Relay Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |